Overexpression of cytoplasmic p 62 protein is associated with poor prognosis in gastric adenocarcinoma

Zhengpeng Li,Yuan Li,Jian Liu,Liya Zhou,Yan Xue,Rongli Cui,Yan Cui,Jinlian Zhou,Jianzhong,Zhang

2016-01-01

Abstract:SQSTM1/p62 (p62) is a multifunctional adapter protein implicated in selective autophagy, cell signaling pathways, and tumorigenesis. Recently, it has been shown that p62 was overexpressed in various malignancies and had implications in the prognosis. In this study, we aim to investigate the expression level of p62 in gastric adenocarcinoma (GA) and evaluate the relationships between its expression and clinical features as well as overall survivals of GA patients. Immunohistochemistry of tissue microarray was used to detect the p62 expression in 90 pairs of GA and nontumorous adjacent mucosa (NAM) samples. The results showed that p62 protein was located in the nucleus and/or cytoplasm in both GA and NAM tissues. The expression level of cytoplasmic p62 in GA tissues was significantly higher than in NAM tissues (P<0.001), while nuclear p62 showed lower expression in GA tissues (P=0.029). In addition, cytoplasmic overexpression of p62 was significantly associated with large tumor size (P=0.018), positive lymphatic invasion (P=0.011) and p62 cytoplasmic expression was different in various major histological types (P=0.036) of GA patients. Kaplan-Meier survival analysis showed that increased cytoplasmic expression of p62 protein was significantly correlated with lower overall survival rate in GA patients (P=0.030). Univariate and multivariate survival analyses indicated that increased cytoplasmic expression of p62 protein was significantly correlated with poor prognosis (P=0.037) but not an independent prognosis factor in GA patients (P=0.222). In conclusion, the results suggest that overexpression of cytoplasmic p62 may contribute to cancer progression and become a novel prognostic biomarker of GA.